7Baggers
 Coherus Shares Tumble Following Quarterly Earnings Report  Ad-hoc-news.de Sun, 16 Nov 2025 04:43:04 GMT
 Coherus Biosciences Divests UDENYCA Business  TipRanks Thu, 13 Nov 2025 22:37:07 GMT
 Coherus at UBS Global Healthcare: Oncology Transition and Growth Plans  Investing.com Mon, 10 Nov 2025 20:31:01 GMT
 Published on: 2025-11-10 04:58:26  newser.com Mon, 10 Nov 2025 10:58:26 GMT
 coherus oncology presents at sitc clinical multiomic  GlobeNewswire Fri, 07 Nov 2025 14:00:00 GMT
 Coherus Oncology appoints Arvind Sood as chief strategy officer By Investing.com  Investing.com Canada Fri, 07 Nov 2025 10:22:16 GMT
 coherus biosciences earnings missed by $0.01, revenue fell short of estimates  Investing.com India Fri, 07 Nov 2025 08:12:43 GMT
 Coherus Oncology Reports Q3 2025 Financial Results  The Globe and Mail Fri, 07 Nov 2025 08:00:00 GMT
 Coherus reports positive data for CCR8+ Treg-depleting antibody  Investing.com Fri, 07 Nov 2025 08:00:00 GMT
 CHRS: Coherus BioSciences Reports Q3 Revenue Below Expectations  GuruFocus Thu, 06 Nov 2025 23:11:30 GMT
 coherus biosciences downgraded to neutral from buy at ubs  TipRanks Thu, 06 Nov 2025 19:12:21 GMT
 Coherus Biosciences reports Q3 EPS (33c), consensus (29c)  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Coherus Oncology Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Coherus Oncology appoints Arvind Sood as chief strategy officer  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 22:01:19  newser.com Thu, 06 Nov 2025 04:01:19 GMT
 published on: 2025-11-05 00:20:33  newser.com Wed, 05 Nov 2025 06:20:33 GMT
 published on: 2025-11-04 23:13:14  newser.com Wed, 05 Nov 2025 05:13:14 GMT
 coherus biosciences approaches critical financial milestone  AD HOC NEWS Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-10-27 05:39:21  newser.com Mon, 03 Nov 2025 08:36:44 GMT
 published on: 2025-11-04 23:13:14  newser.com Mon, 03 Nov 2025 06:56:12 GMT
 published on: 2025-11-01 12:19:03  newser.com Sat, 01 Nov 2025 17:19:03 GMT
 coherus biosciences, inc. (chrs) stock price, news, quote and history  Yahoo! Finance UK Fri, 31 Oct 2025 06:11:41 GMT
 published on: 2025-10-29 21:16:42  newser.com Thu, 30 Oct 2025 02:16:42 GMT
 coherus oncology (chrs) to release quarterly earnings on wednesday  MarketBeat Wed, 29 Oct 2025 08:59:29 GMT
 published on: 2025-10-28 03:00:37  newser.com Tue, 28 Oct 2025 08:00:37 GMT
 published on: 2025-10-27 05:39:21  newser.com Mon, 27 Oct 2025 10:39:21 GMT

Coherus BioSciences, Inc
(NASDAQ:CHRS) 

CHRS stock logo

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline...

Founded: 2010
Full Time Employees: 306
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends